Skip to content

Clinical trials

Cholangiocarcinoma trials in South Korea with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Status: Unknown status Country / region: South Korea Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20161
20171
20212
20223
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wellmarker Bio2
Yonsei University2
Asan Medical Center1
NGM Biopharmaceuticals, Inc1
SMT bio Co., Ltd.1
Samsung Medical Center1
Seoul National University Hospital1
Soonchunhyang University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma10
Pancreatic Neoplasms6
Gallbladder Neoplasms4
Colorectal Neoplasms3
Biliary Tract Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Esophageal Neoplasms2
Head and Neck Neoplasms2
Lung Neoplasms2
Neoplasm Metastasis2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.